Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.366 EUR | +8.93% | +12.52% | +6.06% |
Jun. 14 | Abionyx: positive response from FDA, share price rises | CF |
Jun. 13 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.06% | 47.06M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- Cerenis Therapeutics Announces Appointment of Barbara Yanni to Board of Directors